PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31422719-11 2020 The concomitant development of novel lipids, enhanced understanding of the uptake mechanism and formulation design characteristics have increased lipoplex-based oligonucleotide delivery system access to and success in the clinical trials and regulatory nod. Oligonucleotides 161-176 atrophin 1 Homo sapiens 253-256 21909428-6 2011 The most effective antisense oligonucleotide, (CUG)(7), also reduced mutant ataxin-1 and ataxin-3 mRNA levels in spinocerebellar ataxia 1 and 3, respectively, and atrophin-1 in dentatorubral-pallidoluysian atrophy patient derived fibroblasts. Oligonucleotides 29-44 atrophin 1 Homo sapiens 163-173